The US Centers for Medicare & Medicaid Services (CMS) has announced the July schedule for its virtual Healthcare Common Procedure Coding System (HCPCS) public meetings.
Coding and payments for more than three dozen devices are on the agenda for upcoming virtual public meetings hosted by the Centers for Medicare and Medicaid Services.
The July meetings, announced in the 15 June Federal Register, will discuss requests for new codes or revisions to...
2026 reimbursement calculations for the list of hybrid DRGs – a mechanism to incentivize day cases over inpatient surgery – will be issued in few weeks’ time. The medtech industry has made its demands known.
The FDA's Device Clinical Trial Snapshot Pilot, aimed at increasing trial transparency and diversity, has been canceled following President Trump’s anti-DEI executive order. Critics warn this may hinder trial transparency, impacting public health and demographic data accessibility.
The US FDA posted three warning letters in July, covering medical supply kits, wearables and orthopedics.
Hopes that last-minute negotiations might exempt Brazil’s $300m medtech exports from the latest round of US tariffs have been dashed, leaving the industry braced for further market instability that countermeasures could trigger.
Daye is launching an at-home reproductive hormone testing service in the UK, utilizing a painless upper arm blood collection method. The product’s UKAS lab accreditation helps build credibility with healthcare providers.
BD raised its adjusted earnings per share guidance midpoint by $0.18 to a range of $14.30 to $14.45, representing growth of about 9.4% at the midpoint – an increase of approximately 1.4% over prior guidance.
The US FDA posted three warning letters in July, covering medical supply kits, wearables and orthopedics.
